Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Clarion's CPR-1007 shows antitumor, antipsoriatic and antiinflammatory activity

July 19, 1996

Alfacell's Onconase warrants combination therapy studies

July 19, 1996

More anthracycline antibiotics from Mercian

July 19, 1996

SS-288A/SS-288B: mew anthracycline antibiotics from Mercian

July 19, 1996

ACIC research reveals antineoplastic agents

July 19, 1996

Antitumor platinum complexes disclosed by Boehringer Mannheim

July 19, 1996

IB-367: IntraBiotic's first drug candidate

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Interim phase I/IIa results for Genta's G-3139 as non-Hodgkin's lymphoma agent

July 12, 1996

Canji issued two patents for p53 gene therapy for cancer

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...